1. Novartis CEO Narasimhan touts blockbuster pipeline — Eli Lilly’s generic insulin to be half the price of branded counterpart — JNJ’s Invokana closes in on diabetic kidney disease approval -- See more on our front page news

    Got questions about whistleblowing?: Ask a Whistleblower Attorney
    Dismiss Notice
  2. Dealing with a potential legal issue at work?Ask an Employment Attorney -- a chance to discuss employment-related legal issues with a practicing attorney with over 20 years in employment law experience.
    Dismiss Notice

Reply to Thread

Verification:

(CustomImgCaptcha By Surrey Forum)